Sign in
Etirinotecan pegol (EP, NKTR-102) in the treatment of high-grade glioma (HGG): A phase 2 trial
Journal article   Peer reviewed

Etirinotecan pegol (EP, NKTR-102) in the treatment of high-grade glioma (HGG): A phase 2 trial

Seema Nagpal, Cathy Kahn Recht, Urooj Imtiaz, Sophie Bertrand, Reena Parada Thomas, Abdulrazag Ajlan, Justine Pena, Megan Gershon, Pamela L. Kunz, Gordon Li, …
Journal of clinical oncology, Vol.32(15_suppl), pp.2096-2096
20/05/2014

Abstract

Abstract only

Metrics

1 Record Views

Details